{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/30/3303872/0/en/Cogent-Biosciences-Announces-Detailed-Clinical-Data-from-PEAK-Phase-3-Trial-with-Bezuclastinib-in-Combination-with-Sunitinib-in-Gastrointestinal-Stromal-Tumors-GIST-at-2026-America.html", "message": "News view counter 769096 successfully enlarged"}